48 Results for "

recurrent

" in MedChemExpress (MCE) Product Catalog:
Products (48)

48 Results for "recurrent" in MCE Product Catalog:

Cat. No.: HY-108239R
CAS No.: 1392399-03-9
BIX-01294 trihydrochloride (Standard) is the analytical standard of BIX-01294 (trihydrochloride) (HY-108239). This product is intended for research and analytical applications. BIX-01294 trihydrochloride is a reversible and highly selective G9a and GLP Histone Methyltransferase inhibitor, with IC50s of of 1.7 μM and 0.9 μM, respectively. BIX-01294 trihydrochloride inhibits G9a/GLP by competing for binding with the amino acids N-terminal of the substrate lysine residue. BIX-01294 trihydrochloride, a (1H-1,4-diazepin-1-yl)-quinazolin-4-yl amine derivative, induces necroptosis and autophagy. BIX-01294 trihydrochloride has antitumor activity in recurrent tumor cells .
loading...
    loading...
Cat. No.: HY-157828
CAS No.: 2376765-57-8
Research Areas:  

Neurological Disease Cancer

DSP-0390 is an orally active inhibitor of emopamil binding protein (EBP). DSP-0390 induces cell death by blocking cholesterol biosynthesis in tumor cells. DSP-0390 exhibits antitumor activity in an orthotopic xenograft model of human glioblastoma. DSP-0390 can be used for the research of recurrent high-grade gliomas .
loading...
    loading...
Cat. No.: HY-115499A
CAS No.: 1310540-31-8
Target:  

Drug Intermediate

Research Areas:  

Cancer

MPC-0767 free base is an orally active prodrug of Hsp90 inhibitor. MPC-0767 free base undergoes rapid biotransformation to the parent Hsp90 inhibitor MPC-3100 via enzyme-mediated luminal cleavage. MPC-0767 free base is applicable to the research of refractory and recurrent cancers .
loading...
    loading...
Cat. No.: HY-109050R
CAS No.: 1637771-14-2
Synonyms: GS-5829 (Standard)
Research Areas:  

Cancer

Alobresib (Standard) is the analytical standard of Alobresib (HY-109050). This product is intended for research and analytical applications. Alobresib (GS-5829) is a BET bromodomain inhibitor, which represents a highly effective therapeutics agent against recurrent/chemotherapy resistant uterine serous carcinoma (USC) overexpressing c-Myc. Alobresib can be used in the metastatic castration-resistant prostate cancer (mCRPC) research .
loading...
    loading...
Cat. No.: HY-187797
CAS No.: 2408524-70-7
Synonyms: GSK3882347
Target:  

Bacterial

Research Areas:  

Infection

Luxafimloc (GSK3882347) is a FimH inhibitor and anti-infective agent. Luxafimloc inhibits the activity of the FimH adhesin molecule. Luxafimloc reduces the bacterial load in the bladder of mice with acute cystitis induced by Klebsiella pneumoniae infection. Luxafimloc can be used in studies related to urinary tract infections, including cystitis, uncomplicated urinary tract infection, complicated urinary tract infection, catheter-associated urinary tract infection, acute urinary tract infection, recurrent urinary tract infection, and chronic urinary tract infection .
loading...
    loading...
Cat. No.: HY-187551
CAS No.: 179487-75-3
NPC-18915 free base is a neutrophil activation inhibitor. NPC-18915 free base inhibits CD11b/CD18-mediated neutrophil adhesion. NPC-18915 free base induces shedding of L-selectin on the neutrophil surface, thereby reducing endothelial cell adhesion. NPC-18915 free base inhibits calcium ionophore-induced LTB4 synthesis in neutrophils. NPC-18915 free base reduces the severity of TNBS-induced acute and recurrent colitis in rat experiments. NPC-18915 free base can be used in studies related to colitis .
loading...
    loading...
Cat. No.: HY-P992454

Target:  

Tim3

Research Areas:  

Cancer

S095018 (Sym023) is a human IgG2-type inhibitor targeting T cell immunoglobulin and TIM-3. S095018 competitively blocks the binding of multiple ligands such as Gal-9 and phosphatidylserine to TIM-3. S095018 stimulates the anti-tumor activity of T cells, dendritic cells and macrophages, and exhibits good safety both as a monotherapy and in combination with the anti-PD-1 antibody Sym021. S095018 also induces an increase in the density of CD8 + T cells in the tumor microenvironment, and upregulates gene signatures associated with IFN-γ signaling, antigen presentation and T cell activation. S095018 can be used for the research of advanced/metastatic recurrent biliary tract cancer .
loading...
    loading...
Cat. No.: HY-187641
CAS No.: 299419-24-2
Target:  

Bacterial

Research Areas:  

Infection

ST056083 is a small-molecule inhibitor of the c-di-AMP synthase DisA. The apparent KD of ST056083 binding to DisA is 21 μM. ST056083 reduces c-di-AMP production in Enterococcus faecalis ATCC 29212, and inhibits bacterial growth, biofilm formation, bacterial viability within biofilms, and the synthesis of water-insoluble extracellular polysaccharides. ST056083 is applicable to studies on bacterial c-di-AMP signaling and E. faecalis-associated infections .
loading...
    loading...